Jeffrey A Bluestone San Francisco, CA - 94118

Jeffrey A Bluestone is categorized under Commercial Medical Research in San Francisco, CA and active since 2003.

Jeffrey A Bluestone was established in 2003, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Commercial Medical Research business, which does work in the B2B market, and is classified as a Commercial Medical Research, under code number 541712 by the NAICS.

If you are seeking more information, feel free to contact Jeffrey A Bluestone at the company’s single location by writing to 283 12th Avenue, San Francisco, California CA 94118 or by phoning (415) 514-1683. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Jeffrey A Bluestone
Contact Person: Jeffrey A Bluestone
Address: 283 12th Avenue, San Francisco, California 94118
Phone Number: (415) 514-1683
Website Address: diabetes.ucsf.edu
Annual Revenue (USD): $100.000 to $499.999
Founded: 2003
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Commercial Medical Research
SIC Code: 8731
NAICS Code: 541712
Share This Business:

Jeffrey A Bluestone was started in 2003 to provide professional Commercial Medical Research under the SIC code 8731 and NAICS code 541712. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact Jeffrey A Bluestone for inquiries that concern Jeffrey A Bluestone by calling the company number (415) 514-1683, as your correspondence is most welcome. Additionally, the physical location of the single location of Jeffrey A Bluestone can be found at the coordinates 37.783015,-122.47105 as well as the street address 283 12th Avenue in San Francisco, California 94118.

For its online presence, you may visit Jeffrey A Bluestone’s website at diabetes.ucsf.edu and engage with its social media outlets through on Twitter and on Facebook.